Acquired hypoprothrombinemia: Effects of Danazol® treatment

American Journal of Hematology

Volumn 53, Issue 4, 1996, Pages 272-276

  Williams, Sybil ^a   Linardic, Corinne ^a   Wilson, Olga ^a   Comp, Philip ^b   Gralnick, Harvey R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Danazol ; discoid lupus erythematosus; factor II; factor IX; factor X; hypoprothrombinemia; lupus anticoagulant; protein C; protein S

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 9; DANAZOL; LUPUS ANTICOAGULANT; PREDNISONE; PROTEIN C; PROTHROMBIN; SIALIDASE;

ARTICLE; DISCOID LUPUS ERYTHEMATOSUS; HYPOPROTHROMBINEMIA; PRIORITY JOURNAL;

BLOOD LOSS, SURGICAL; COLONIC POLYPS; DANAZOL; HUMANS; HYPOPROTHROMBINEMIAS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGED; PROTHROMBIN TIME;

EID: 0029957399     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199612)53:4<272::AID-AJH14>3.0.CO;2-E     Document Type: Article

References (12)

1. Rapaport SI, Feinstein DI: Lupus anticoagulant and Other Hemostatic Problems. In Wallace DJ, Dubois EL (eds): "Dubois' Lupus Erythematosus," Ed 3. Philadelphia: Lea and Febiger, 1987, p 271.
2. Fleck RA, Rapaport SI, Rao LVM: Anti-prothrombin antibodies and the lupus anticoagulant. Blood 72:512, 1988.
3. Rapaport SI, Ames SB, Duval BJ: A plasma coagulation defect in systemic lupus erythematosus arising from hypoprothrombinemia combined with antiprothrombinase activity. Blood 15:212, 1960.
4. Bajaj SP, Rapaport SI, Fierer DS: A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 61:684, 1983.
5. Bajaj SP, Rapaport SI, Barclay S, Herbert KD: Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: Mechanism and management. Blood 65:1538, 1985.
6. Natelson EA, Cyprus GS, Hettig RA: Absent factor II in systemic lupus erythematosus. Immunologic studies and response to corticosteroid therapy. Arthritis Rheum 19:79, 1976.
7. Lillquist KB, Dyerberg J, Krogh-Jensen M: Case report: The absence of factor II in a child with systemic lupus erythematosus. Acta Paediatr Scand 67:533, 1978.
8. Edson JR, Vogt JM, Hasegowa DK: Abnormal prothrornbin crossed- immunoelectrophoresis in patients with lupus inhibitors. Blood 64:807, 1984.
9. Laurell CB, Rannevik G: A comparison of plasma protein changes induced by Danazol®, pregnancy, and estrogens. J Clin Endocrinol Metab 49:719, 1979.
10. Al-Momen AK, Gader AMA, Shamena A-R, Daif AK: Significant evaluation of protein C and protein S levels in thrombotic disorders by low dose Danazol.® Blood Coag Fibrinol 2:495, 1991.
11. Laurell CB: Electroimmunoassay. Scand J Clin Lab Invest 29 (Suppl 124):21, 1972.
12. Denson KW, Borrett K, Biggs R: The specific assay of prothrombin using the Taipan snake venom. Brit J Haemat 21:219, 1971.